• AXT, Inc. reported second-quarter 2026 results showing sales of US$47.59 million and net income of US$11.13 million, alongside a long-term indium phosphide supply and capacity reservation agreement with Lumentum Operations, LLC that includes US$87,000,000 in deposits applied as shipment credits through 2031.
• These developments mark a shift from prior-period losses to profitability while securing multi-year product demand and upfront customer funding that could influence how investors view AXT’s earnings quality and capacity planning.
• Next, we’ll examine how this long-term indium phosphide capacity reservation with Lumentum may reshape AXT’s existing investment narrative and risk profile.

Find 55 companies with promising cash flow potential yet trading below their fair value.

AXT Investment Narrative Recap

To own AXT today you have to believe its compound semiconductor substrates can translate into durable, profitable demand, especially in indium phosphide for high‑speed optics. The Q2 2026 swing to profitability and the long‑term Lumentum agreement support that thesis by locking in multi‑year volumes and upfront deposits, potentially making earnings less volatile. The biggest near term risk remains supply and export constraints for key wafers, and this deal does not remove that exposure.

The Lumentum capacity reservation stands out as the most relevant development here. A minimum commitment through 2031, backed by US$87,000,000 in shipment credits, gives AXT clearer line of sight on demand for a core growth product. For investors focused on catalysts like better factory utilization and improved earnings quality, this agreement ties directly to those themes, while also concentrating AXT further around a small group of important customers.

But against the optimism around this Lumentum deal, investors should be aware of how fragile AXT’s position could become if export permits again start to...

AXT's narrative projects $374.9 million revenue and $141.0 million earnings by 2029.

Uncover how AXT's forecasts yield a $96.50 fair value, a 60% upside to its current price.

Exploring Other Perspectives

Before this news, the most pessimistic analysts already expected about US$404.3 million of revenue and US$210.0 million of earnings by 2029, yet they still highlighted export permit risks as potentially limiting AXT’s access to key markets, so it is worth considering how such cautious views might shift after a multi year, US$87,000,000 Lumentum commitment.

Explore 5 other fair value estimates on AXT - why the stock might be worth over 2x more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your AXT research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free AXT research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate AXT's overall financial health at a glance.

Contemplating Other Strategies?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Uncover the next big thing with 21 elite penny stocks that balance risk and reward.
• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.